Partial unilateral lentiginosis

From WikiMD's WELLNESSPEDIA


Partial unilateral lentiginosis
Synonyms PUL
Pronounce N/A
Specialty N/A
Symptoms Lentigines on one side of the body
Complications None
Onset Childhood or adolescence
Duration Lifelong
Types N/A
Causes Unknown
Risks Genetic predisposition
Diagnosis Clinical diagnosis
Differential diagnosis Neurofibromatosis, Segmental pigmentation disorder
Prevention N/A
Treatment Laser therapy, Topical depigmenting agents
Medication N/A
Prognosis Good
Frequency Rare
Deaths N/A


Partial Unilateral Lentiginosis (PUL) is a rare cutaneous condition characterized by numerous lentigines grouped within an area of normal skin; these are usually present at birth or appear in early childhood, and do not cross the midline of the body.[1]

Clinical Presentation[edit]

The condition is characterized by the presence of multiple lentigines, which are small, pigmented spots on the skin that are darker than the surrounding skin. These spots are typically grouped within an area of normal skin and are usually present at birth or appear in early childhood. The lentigines do not cross the midline of the body, meaning they are present on only one side of the body.[2]

Diagnosis[edit]

The diagnosis of Partial Unilateral Lentiginosis is primarily based on the clinical presentation of the patient. A dermatologist may perform a skin biopsy to confirm the diagnosis and rule out other conditions that may present with similar symptoms.[3]

Treatment[edit]

There is currently no cure for Partial Unilateral Lentiginosis. Treatment is primarily aimed at managing the symptoms and improving the appearance of the skin. This may include the use of topical creams, laser therapy, or surgical removal of the lentigines.[4]

See Also[edit]

References[edit]

  1. "Andrews' Diseases of the Skin: clinical Dermatology".2006;
    691.
  2. "Andrews' Diseases of the Skin: clinical Dermatology".2006;
    691.
  3. "Andrews' Diseases of the Skin: clinical Dermatology".2006;
    691.
  4. "Andrews' Diseases of the Skin: clinical Dermatology".2006;
    691.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.